Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke

Jia Jia, Saurabh Verma, Shin Nakayama, Nidia Quillinan, Marjorie Grafe, Patricia D. Hurn, Paco S. Herson

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The calcium-permeable transient receptor potential M2 (TRPM2) ion channel is activated following oxidative stress and has been implicated in ischemic damage; however, little experimental evidence exists linking TRPM2 channel activation to damage following cerebral ischemia. We directly assessed the involvement of TRPM2 channels in ischemic brain injury using pharmacological inhibitors and short-hairpin RNA (shRNA)-mediated knockdown of TRPM2 expression. Each of the four TRPM2 inhibitors tested provided significant protection to male neurons following in vitro ischemia (oxygen-glucose deprivation, OGD), while having no effect in female neurons. Similarly, TRPM2 knockdown by TRPM2 shRNA resulted in significantly reduced neuronal cell death following OGD only in male neurons. The TRPM2 inhibitor clotrimazole reduced infarct volume in male mice, while having no effect on female infarct volume. Finally, intrastriatal injection of lentivirus expressing shRNA against TRPM2 resulted in significantly smaller striatal infarcts only in male mice following middle cerebral artery occlusion, having no significant effect in female mice. Data presented in the current study demonstrate that TRPM2 inhibition and knockdown preferentially protects male neurons and brain against ischemia in vitro and in vivo, indicating that TRPM2 inhibitors may provide a new therapeutic approach to the treatment of stroke in men.

Original languageEnglish (US)
Pages (from-to)2160-2168
Number of pages9
JournalJournal of Cerebral Blood Flow and Metabolism
Volume31
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Transient Receptor Potential Channels
Sex Characteristics
Stroke
Small Interfering RNA
Neurons
Brain Ischemia
Oxygen
Clotrimazole
Corpus Striatum
Glucose
Lentivirus
Middle Cerebral Artery Infarction
Ion Channels
Brain Injuries
Oxidative Stress
Cell Death
Ischemia
Neuroprotection
Pharmacology
Calcium

Keywords

  • ischemia
  • neuroprotection
  • stroke
  • TRPM2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Neurology

Cite this

Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. / Jia, Jia; Verma, Saurabh; Nakayama, Shin; Quillinan, Nidia; Grafe, Marjorie; Hurn, Patricia D.; Herson, Paco S.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 31, No. 11, 11.2011, p. 2160-2168.

Research output: Contribution to journalArticle

Jia, Jia ; Verma, Saurabh ; Nakayama, Shin ; Quillinan, Nidia ; Grafe, Marjorie ; Hurn, Patricia D. ; Herson, Paco S. / Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. In: Journal of Cerebral Blood Flow and Metabolism. 2011 ; Vol. 31, No. 11. pp. 2160-2168.
@article{18507b6d76f143c485d3c148190e1363,
title = "Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke",
abstract = "The calcium-permeable transient receptor potential M2 (TRPM2) ion channel is activated following oxidative stress and has been implicated in ischemic damage; however, little experimental evidence exists linking TRPM2 channel activation to damage following cerebral ischemia. We directly assessed the involvement of TRPM2 channels in ischemic brain injury using pharmacological inhibitors and short-hairpin RNA (shRNA)-mediated knockdown of TRPM2 expression. Each of the four TRPM2 inhibitors tested provided significant protection to male neurons following in vitro ischemia (oxygen-glucose deprivation, OGD), while having no effect in female neurons. Similarly, TRPM2 knockdown by TRPM2 shRNA resulted in significantly reduced neuronal cell death following OGD only in male neurons. The TRPM2 inhibitor clotrimazole reduced infarct volume in male mice, while having no effect on female infarct volume. Finally, intrastriatal injection of lentivirus expressing shRNA against TRPM2 resulted in significantly smaller striatal infarcts only in male mice following middle cerebral artery occlusion, having no significant effect in female mice. Data presented in the current study demonstrate that TRPM2 inhibition and knockdown preferentially protects male neurons and brain against ischemia in vitro and in vivo, indicating that TRPM2 inhibitors may provide a new therapeutic approach to the treatment of stroke in men.",
keywords = "ischemia, neuroprotection, stroke, TRPM2",
author = "Jia Jia and Saurabh Verma and Shin Nakayama and Nidia Quillinan and Marjorie Grafe and Hurn, {Patricia D.} and Herson, {Paco S.}",
year = "2011",
month = "11",
doi = "10.1038/jcbfm.2011.77",
language = "English (US)",
volume = "31",
pages = "2160--2168",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke

AU - Jia, Jia

AU - Verma, Saurabh

AU - Nakayama, Shin

AU - Quillinan, Nidia

AU - Grafe, Marjorie

AU - Hurn, Patricia D.

AU - Herson, Paco S.

PY - 2011/11

Y1 - 2011/11

N2 - The calcium-permeable transient receptor potential M2 (TRPM2) ion channel is activated following oxidative stress and has been implicated in ischemic damage; however, little experimental evidence exists linking TRPM2 channel activation to damage following cerebral ischemia. We directly assessed the involvement of TRPM2 channels in ischemic brain injury using pharmacological inhibitors and short-hairpin RNA (shRNA)-mediated knockdown of TRPM2 expression. Each of the four TRPM2 inhibitors tested provided significant protection to male neurons following in vitro ischemia (oxygen-glucose deprivation, OGD), while having no effect in female neurons. Similarly, TRPM2 knockdown by TRPM2 shRNA resulted in significantly reduced neuronal cell death following OGD only in male neurons. The TRPM2 inhibitor clotrimazole reduced infarct volume in male mice, while having no effect on female infarct volume. Finally, intrastriatal injection of lentivirus expressing shRNA against TRPM2 resulted in significantly smaller striatal infarcts only in male mice following middle cerebral artery occlusion, having no significant effect in female mice. Data presented in the current study demonstrate that TRPM2 inhibition and knockdown preferentially protects male neurons and brain against ischemia in vitro and in vivo, indicating that TRPM2 inhibitors may provide a new therapeutic approach to the treatment of stroke in men.

AB - The calcium-permeable transient receptor potential M2 (TRPM2) ion channel is activated following oxidative stress and has been implicated in ischemic damage; however, little experimental evidence exists linking TRPM2 channel activation to damage following cerebral ischemia. We directly assessed the involvement of TRPM2 channels in ischemic brain injury using pharmacological inhibitors and short-hairpin RNA (shRNA)-mediated knockdown of TRPM2 expression. Each of the four TRPM2 inhibitors tested provided significant protection to male neurons following in vitro ischemia (oxygen-glucose deprivation, OGD), while having no effect in female neurons. Similarly, TRPM2 knockdown by TRPM2 shRNA resulted in significantly reduced neuronal cell death following OGD only in male neurons. The TRPM2 inhibitor clotrimazole reduced infarct volume in male mice, while having no effect on female infarct volume. Finally, intrastriatal injection of lentivirus expressing shRNA against TRPM2 resulted in significantly smaller striatal infarcts only in male mice following middle cerebral artery occlusion, having no significant effect in female mice. Data presented in the current study demonstrate that TRPM2 inhibition and knockdown preferentially protects male neurons and brain against ischemia in vitro and in vivo, indicating that TRPM2 inhibitors may provide a new therapeutic approach to the treatment of stroke in men.

KW - ischemia

KW - neuroprotection

KW - stroke

KW - TRPM2

UR - http://www.scopus.com/inward/record.url?scp=80455164731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455164731&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2011.77

DO - 10.1038/jcbfm.2011.77

M3 - Article

VL - 31

SP - 2160

EP - 2168

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 11

ER -